In response to a question directed to respondents whose organizations dont already cover GLP-1 medications for weight loss, 70% said they werent considering adding coverage, or a health reimbursement arrangement (HRA), in the future
Figure 2 Table 2 Variability of the sequences of mammalian proglucagon-derived peptides
GLP-1 drugs alone have a very powerful track record of safety, Drucker said, but every time we add something to it, were starting again. And even just targeting one hormone, GLP-1, has been transformative
doi:10.1111/bcp.16401 215
Ozempic Initially developed for type 2 diabetes , but now widely prescribed off-label for weight loss
Lower Inflammatory Load : Supplemented patients recorded significant drops in pro-inflammatory cytokines that sustain chronic immune exhaustion in diabetic subjects